A stepwise, evidence-based algorithm for initiating, advancing, and maintaining EN in critically ill children was developed using a multidisciplinary consensus approach. A full description of the ...
YARDLEY, Pa., June 2, 2021 /PRNewswire/ — Optinose (NASDAQ:OPTN), a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy ...
A new study undertaken by the Medical Research Institute of New Zealand (MRINZ) shows that adults with asthma can safely simplify their treatment, reduce overall steroid exposure and improve asthma ...
Investigators substantiated strategies to encourage approval rates for proprotein convertase subtilisin/kexin type 9 inhibitors. Many prescription claims for proprotein convertase subtilisin/kexin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results